Ricovr Healthcare Awarded NIH Grant to Advance Development of Point-of-Care Cannabis Screening Platform
Ricovr Healthcare secures NIH grant to develop XALIVA®, an innovative cannabis screening device, aiming to
Ricovr Healthcare secures NIH grant to develop XALIVA®, an innovative cannabis screening device, aiming to
PUERTO RICO, USA, July 15, 2024 /EINPresswire.com/ — Ricovr Healthcare announces its selection to present
[Princeton, NJ, Feb 19 2024] – Ricovr Healthcare, a pioneering company dedicated to promoting fairness
Ricovr Healthcare, a leading innovator in the lab and point-of-care diagnostics industry, announces the appointment
(Jo McGuire Joins Ricovr: Pioneering the Future of Drug-
Free Workplaces)
Carra Wallace to join RICOVR Healthcare’s distinguished advisory board Princeton, NJ, July 19, 2023: RICOVR
The P-FAB technology was 100% accurate compared to the gold standard mass spectrometry for detecting
Maternal and Infant Health R&D Grant will support further development of the XALIVA® rapid diagnostics
Trenton, N.J. (January 20, 2023) – The Commission on Science, Innovation and Technology (CSIT) Board
Princeton, NJ, September 26, 2022: RICOVR Healthcare the creator of XALIVA® THC rapid drug test
At COO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions
The Tech Tribune staff has compiled the very best tech startups in Princeton, New Jersey. In
Point-of-care drug testing devices can accurately detect drugs-of-abuse and increase safety within communities & workplaces.
Venture capitalists and bankers convened at Grounds for Sculpture (Hamilton) this month, mostly without masks,
PRINCETON, NJ, UNITED STATES, July 13, 2021 /EINPresswire.com/ — RICOVR Healthcare, creator of the XALIVA™ rapid
RICOVR Healthcare announced that it has raised $1.5 million in funding to commercialize its point-of-care
Ricovr Healthcare is one of Business Insider’s 26 hottest cannabis startups that are set to
New York VC Network has compiled its first public NYC Top 50 list of companies
Because of the current economic climate our publication has started a series of discussions with
Forbes Ben Baldanza Contributor Aerospace & Defense I write about airlines and travel to explain
A new rapid saliva-based antigen test has been developed in Princeton as COVID-19 cases rise